These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Comparison of acute myeloid leukemia occurring de novo or preceded by a myelodysplastic stage: differences in cellular DNA content. Widell S; Auer G; Hast R; Reizenstein P Am J Hematol; 1993 Mar; 42(3):293-8. PubMed ID: 8438903 [TBL] [Abstract][Full Text] [Related]
24. [Five cases of de novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) achieved CR with the continuous drip infusion of low-dose etoposide and low-dose cytosine arabinoside combined with mitoxantrone (MEtA)]. Tsukaguchi M; Furukawa Y; Shibano M; Kitani T Gan To Kagaku Ryoho; 2004 Jul; 31(7):1119-23. PubMed ID: 15272598 [TBL] [Abstract][Full Text] [Related]
25. Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients. Xu XQ; Wang JM; Gao L; Qiu HY; Chen L; Jia L; Hu XX; Yang JM; Ni X; Chen J; Lü SQ; Zhang WP; Song XM Am J Hematol; 2014 Sep; 89(9):874-81. PubMed ID: 24861848 [TBL] [Abstract][Full Text] [Related]
26. Cell-lineage level-targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes. Yokoyama K; Shimizu E; Yokoyama N; Nakamura S; Kasajima R; Ogawa M; Takei T; Ito M; Kobayashi A; Yamaguchi R; Imoto S; Miyano S; Tojo A Blood Adv; 2018 Oct; 2(19):2513-2521. PubMed ID: 30282643 [TBL] [Abstract][Full Text] [Related]
27. Differences in cell lineage involvement between MDS-AML and de novo AML studied by fluorescence in situ hybridization in combination with morphology. Bernell P; Arvidsson I; Hast R; Jacobsson B; Stenke L Eur J Haematol; 1997 Apr; 58(4):241-5. PubMed ID: 9186534 [TBL] [Abstract][Full Text] [Related]
28. Myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) with myelofibrosis. Imbert M; Nguyen D; Sultan C Leuk Res; 1992; 16(1):51-4. PubMed ID: 1732672 [TBL] [Abstract][Full Text] [Related]
29. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2). Ogasawara T; Yasuyama M; Kawauchi K Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101 [TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders. Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372 [TBL] [Abstract][Full Text] [Related]
31. Therapy-related myelodysplastic syndrome/acute myeloid leukemia with del(7)(q22) in a patient with de novo AML. Kim YG; Cho SY; Park TS; Oh SH; Yoon HJ Ann Clin Lab Sci; 2011; 41(1):79-83. PubMed ID: 21325260 [TBL] [Abstract][Full Text] [Related]
32. [Clonal analysis by fluorescence in situ hybridization in a patient with de nove acute myeloid leukemia with myelodysplasia]. Hyakuna N; Naritomi K; China K; Gushiken T; Tohma T; Ito E Rinsho Ketsueki; 1997 Sep; 38(9):776-81. PubMed ID: 9364870 [TBL] [Abstract][Full Text] [Related]
33. [Study on the transformation from myelodysplastic syndromes into acute leukemias]. Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096 [TBL] [Abstract][Full Text] [Related]
34. Application of long-term bone marrow cultures for studying the leukemic transformation of myelodysplastic syndromes. Kanamaru A; Tamura S Leuk Lymphoma; 1993 Nov; 11(5-6):345-52. PubMed ID: 8124206 [TBL] [Abstract][Full Text] [Related]
35. Cytogenetic Studies in Patients with Acute Myeloid Leukemia Following a Myelodysplastic Syndrome. Weh HJ; Kuse R; Seeger D; Suciu S; Hossfeld DK Leuk Lymphoma; 1991; 3(5-6):423-7. PubMed ID: 27467434 [TBL] [Abstract][Full Text] [Related]
36. Therapy-related acute myeloid leukaemia and myelodysplastic syndrome in Victoria, Australia 2003-2014. Ong DM; Farrugia H; Wei A Intern Med J; 2018 Jul; 48(7):822-829. PubMed ID: 29236346 [TBL] [Abstract][Full Text] [Related]
37. p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia. Kitagawa M; Yoshida S; Kuwata T; Tanizawa T; Kamiyama R Am J Pathol; 1994 Aug; 145(2):338-44. PubMed ID: 8053492 [TBL] [Abstract][Full Text] [Related]
38. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881 [TBL] [Abstract][Full Text] [Related]
39. Cell-cycle progression rates and sister chromatid exchange frequencies in the bone marrow of patients with myelodysplastic syndrome and acute myeloid leukemia. Jones BM; White AD; Culligan DJ; Jacobs A Cancer Genet Cytogenet; 1992 Aug; 62(1):66-9. PubMed ID: 1521237 [TBL] [Abstract][Full Text] [Related]
40. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases. Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]